期刊文献+

动静脉插管体外循环顺铂加温灌注化疗下肢恶性肿瘤的保肢治疗研究 被引量:3

Study of the extrimites salvage surgery with Shubo and hyperthermia perfusion for limbs malignant tumors
下载PDF
导出
摘要 目的:探讨顺铂加温灌注化疗对下肢恶性肿瘤的杀伤作用及其对保肢、提高5年生存率的价值。方法:体外循环机连接股动静脉插管,加入顺铂200mg,持续加温灌注60min。灌注2至3周后行肿瘤大块切除或肿瘤骨段切除重建术。结果:疼痛消失,肿瘤缩小,关节功能改善。X线示肿瘤阴影缩小,边界清楚,密度增高;病理检查可见肿瘤细胞广泛坏死,胞浆和胞核消失。随访22例,时间1个月至5年,平均2年3个月,无局部复发,肺部转移死亡2例,带肺转移瘤生存1例,无瘤生存19例。结论:体外循环顺铂加温灌注化疗对肿瘤细胞具有很大的杀伤作用,可明显缓解局部疼痛,使肿瘤缩小,是保肢治疗的一个有效方法。 Purpose: to study the therapeutic efficacy of Shubo using isolation limb perfusion(ILP) with hyperthermia for malignant tumors Methods:23 patients received ILP The Shubo 200mg was injected in the arterial line, under hyperthermic conditions (42 to 43) for 60minutes Results:22 of 23 cases showed pain subsidence, tumor mass remission and joint motion improvement one patient died of kidney failure after ILP Necrosis of the tumour tissue occurred in 90% ̄97% Twenty-two cases were followed up for 26 years(range, 1 to 60 months) In followed patients, twenty cases were alive(1 of 20 patient was alive with metastatic tumour of lung) and 2 cases died of metastatic tumour of lung none patient had recurrence of tumour Conclusion: this study suggested that Shubo and ILP for lower extrimites malignant tumors may achieve good efficacy under hyperthermic conditions(42 to 43)\=\ \
出处 《广西医学》 CAS 1999年第4期603-606,共4页 Guangxi Medical Journal
基金 广西自然科学基金
关键词 顺铂 加温灌注 恶性肿瘤 下肢肿瘤 药物疗法 Shubo Isolation limb perfution Malignant tumors Treatment of extrimites salvage surgery\=
  • 相关文献

参考文献2

共引文献31

同被引文献25

  • 1杨蕴,宋金钢,朱靖,滕胜,马育林,张瑾,邢汝维.下肢恶性骨肿瘤顺铂热灌注治疗的血铂浓度测定[J].中华骨科杂志,2003,23(6):335-338. 被引量:1
  • 2徐世伟,陈芳,赵玉华.下肢骨肉瘤区域高温隔离灌注化疗方法学的探讨[J].中华肿瘤杂志,1994,16(4):310-313. 被引量:9
  • 3徐世伟,陈芳,赵玉华.下肢骨肉瘤区域高温隔离灌注化疗并发症的预防[J].中国肿瘤临床,1996,23(11):793-795. 被引量:1
  • 4[1]Decian F, Balletto N, Camerini G, et al. Hyperthermic antiblastic isolation perfusion for advanced melnoma of the limbs. The technic, immediate results and a review of the literature. Minerva chir, 1990, 15:45:1227-1237.
  • 5[2]Carlo R R, Antonella V, Mirto F, et al. Phase Ⅱ study on heoadjavant hyperthermic antiblastic perfusion with doxorubicin inpatient with intermediate or high grade limb sarcomas. Cancer, 1994,73:2140 - 2146.
  • 6[3]Klasse J M, Kroon BBR, Benckhuijsen C, et al. Results of regional isolation perfusion with cytostatics inpatiens with soft tissue tumors of the extremities. Cancer, 1989,64:612 - 621.
  • 7[4]Krementz ET. Regional perfusion: current sophistication, what next? Cancer, 1986,57:416 - 432.
  • 8[7]Guchelaar H J, Hoekstra H J, Devries EGE, et al. Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities. Br J Cancer, 1992,65: 898 - 902
  • 9[1]Rha SY,Chung HC,Gong SJ,et al,Combined preoperative chemotherapy with intra arterial cisplatin and continuous intravenousadriamyein for high grade ostcosarcoma.Oncol Rep,1999,6:631-637.
  • 10[2]Jaffe N,Patel SR,Benjamin RS.Chemotherapy in osteosarcoma.Hematol Oncol Clin Noah Am,1995,9:825-840.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部